Drug intelligence / Profile preview

germander

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Germander refers primarily to *Teucrium chamaedrys*, a perennial herb in the mint family (Lamiaceae) native to central and southern Europe, North Africa, and the Middle East. Its aerial parts have been used historically in traditional medicine for conditions such as gout, diabetes, obesity, digestive complaints, fever, and inflammatory conditions. Mechanistically, germander contains numerous bioactive compounds, most notably furan-containing neoclerodane diterpenoids (e.g., teucrin A, teuchmaedryn A), which are implicated in its marked hepatotoxicity, as they are metabolized by cytochrome P450 enzymes into reactive metabolites causing liver cell injury via glutathione depletion and protein binding. Despite its historical uses, germander is considered likely unsafe and is banned for oral use in several countries due to its association with severe and sometimes fatal liver injury. Its therapeutic benefit in humans is unproven; current use is extremely limited and generally discouraged[1][4][5].

Other names
Teucrium chamaedryswall germanderteucriumteucrium herbteucrium chamaedrys herb
02

Targets

CYP3A (CYP3A family)

Beyond the preview

Go deeper on germander.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on germander.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call